-
21.
公开(公告)号:US20190298784A1
公开(公告)日:2019-10-03
申请号:US16382669
申请日:2019-04-12
发明人: Myung Jun CHUNG
IPC分类号: A61K35/745 , A23L33/135 , C12N1/20 , C12R1/01
摘要: The present invention relates to a novel Bifidobacterium strain having an excellent growth promoting effect, and a nutraceutical composition for promotion of growth, which contains the strain. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.
-
22.
公开(公告)号:US20200325439A1
公开(公告)日:2020-10-15
申请号:US16839289
申请日:2020-04-03
发明人: Myung Jun CHUNG
IPC分类号: C12N1/20 , A23L33/135 , A23L33/18 , A23L33/125 , A23L33/19 , A23J3/34 , A23L33/185 , A23P20/10 , A23L3/44 , C12N1/04 , C12P21/06
摘要: The present disclosure relates to a method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using a protein hydrolysate, and lactic acid bacteria having a dual coating, produced by the method. The lactic acid bacteria having a dual coating of protein and polysaccharide, produced according to the present disclosure, have very excellent dry-freezing viability, acid resistance and bile resistance. Accordingly, the lactic acid bacteria having a dual coating of protein and polysaccharide according to the present disclosure will be very useful for the production of fermented milk, processed milk, fermented soy products, processed foods, functional beverages, functional foods, common foods, etc.
-
公开(公告)号:US10597740B2
公开(公告)日:2020-03-24
申请号:US16374885
申请日:2019-04-04
发明人: Myung Jun Chung
IPC分类号: A61K39/02 , C12R1/01 , C12N1/20 , A23L33/135 , A61K35/745 , A23L2/52
摘要: The present invention a Bifidobacterium longum CBT BG7 Bifidobacterium, which has an excellent growth promoting effect and was internationally deposited with the Korean Collection for Type Culture (KCTC) of the Korea Research Institute of Bioscience and Biotechnology under accession number KCTC 12200BP. The strain of the present invention has a beneficial effect of promoting growth by promoting the digestion of human milk oligosaccharides to enhance immunity together with physical strength.
-
公开(公告)号:US20190330312A1
公开(公告)日:2019-10-31
申请号:US16471912
申请日:2018-10-16
发明人: Myung Jun CHUNG
摘要: The present invention relates to a microorganism for drug delivery, which has been transformed with a gene construct including a therapeutically active peptide, is delivered safely into the intestines through oral administration, and expresses and secretes a cystatin in the gastrointestinal tract, and also relates to a pharmaceutical composition for prevention or treatment of gastrointestinal disease, which includes the same. The present invention demonstrates the safety and superiority of lactic acid bacteria as a system for delivering a protein-based drug, and thus it is expected the lactic acid bacteria will be widely used as an agent for treatment of gastrointestinal disease in the medical field.
-
公开(公告)号:US20190201481A1
公开(公告)日:2019-07-04
申请号:US16303208
申请日:2017-02-15
发明人: Myung Jun CHUNG
IPC分类号: A61K38/16 , A61K35/744 , A61P35/00 , A23L33/18
CPC分类号: A61K38/164 , A23L33/18 , A23V2002/00 , A61K35/744 , A61K38/16 , A61K2035/115 , A61P35/00 , C07K14/335 , C12N15/74 , Y02A50/475
摘要: The present invention relates to a protein derived from lactic acid bacteria and a method for producing the same. The lactic acid bacteria-derived protein of the present invention is a purified protein isolated from lactic acid bacteria (Lactobacillus rhamnosus) having an excellent therapeutic effect against colorectal cancer. It has been demonstrated to have a remarkable effect against colorectal diseases, and thus is expected to be widely used as a natural protein therapeutic agent against colorectal diseases in the medical field.
-
-
-
-